Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Israeli unions warn Teva Pharm over plan to close Ashdod plant
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
US court invalidates key TEVA drug patent
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
TEVA.N - | Stock Price & Latest News | Reuters
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva's proposed settlement could cost drugmaker pennies on the dollar - The Jerusalem Post
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, Viatris win U.S. appeal in patent fight over Parkinson's drug | Reuters
Teva Pharmaceutical CFO to step down: media | Reuters.com
Teva Tries to Put an End to the Opioid Wars - WSJ
U.S. states sue Mylan, Teva, others for fixing drug prices - Mitchell Republic | News, weather, sports from Mitchell South Dakota
TEVA.N - | Stock Price & Latest News | Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Teva Pharm bets on neurology drugs for growth as Q1 profit misses | Reuters
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
